Overview

Grape seed extract (GSE) is derived from the seeds of Vitis vinifera (wine grapes) and is highly concentrated in oligomeric proanthocyanidins (OPCs), also called procyanidins—a class of condensed tannins composed of catechin and epicatechin monomers linked in oligomeric chains. GSE is one of the most potent naturally occurring antioxidants and has clinical evidence in venous insufficiency, blood pressure reduction, platelet aggregation, skin health, and cognitive protection. Pycnogenol (French maritime pine bark extract) contains a similar OPC profile and is often considered alongside GSE; both are covered here with distinctions noted.

Mechanism of Action

Antioxidant: OPCs neutralize hydroxyl radicals, superoxide, and peroxynitrite with approximately 20× the antioxidant potency of vitamin C and 50× vitamin E in vitro. They also regenerate vitamins C and E from their oxidized forms and chelate Fe²⁺ and Cu²⁺ to prevent Fenton chemistry.

Endothelial function: OPCs stimulate eNOS activity → increased NO production → vasodilation and reduced platelet adhesion. They also inhibit ACE (angiotensin-converting enzyme), contributing to blood pressure lowering.

Collagen protection: OPCs inhibit collagenase, elastase, and hyaluronidase—enzymes that degrade connective tissue extracellular matrix. This explains their therapeutic application in venous insufficiency (strengthening vessel walls) and skin health.

Anti-inflammatory: OPCs inhibit NF-κB, COX-2, and LOX, reducing PGE2 and histamine release. Relevant to inflammatory conditions and allergic responses.

Platelet: OPCs inhibit ADP- and collagen-induced platelet aggregation, reducing thrombotic risk.

Evidence Base

Chronic venous insufficiency (CVI): GSE and Pycnogenol have the strongest RCT evidence in CVI. Multiple trials (100–300 mg/day OPCs) show significant reductions in leg edema, heaviness, cramps, and capillary permeability vs. placebo over 4–12 weeks. Pycnogenol is licensed in France for CVI.

Blood pressure: A 2016 meta-analysis (9 RCTs, 641 subjects) found GSE supplementation significantly reduced systolic BP (mean −6.08 mmHg) and diastolic BP (mean −2.8 mmHg). Effect was most pronounced in younger subjects and metabolic syndrome patients.

Metabolic syndrome / LDL oxidation: RCTs show OPCs reduce oxidized LDL, total LDL, improve endothelial flow-mediated dilation, and reduce CRP in metabolic syndrome.

Cognitive aging / ADHD: Pycnogenol (1 mg/kg/day for 3 months) improved ADHD symptom scores in children in one RCT. Studies in older adults show improved memory scores and attention. Mechanism: increased BDNF, reduced oxidative stress in brain.

Skin protection: OPCs support collagen cross-linking and protect against UV-induced oxidation; some evidence for reduced age spots and improved skin elasticity in oral supplementation RCTs.

Dosing & Timing

Application Dose Notes
Chronic venous insufficiency 150–300 mg OPC/day Standardized GSE or Pycnogenol; with meals
Blood pressure support 150–300 mg/day 4–8 week trials; with meals
General antioxidant / cardiovascular 100–200 mg/day Maintenance dose
Cognitive / ADHD 1 mg/kg/day Pycnogenol Research dose; 60–100 mg/day for adults

Forms & Bioavailability

  • Grape seed extract (GSE): Standardized to ≥95% OPCs; most widely available supplement form; inexpensive.
  • Pycnogenol (Horphag Research): French maritime pine bark; 65–75% procyanidins; more extensively studied; slightly different OPC profile; premium price.
  • MegaNatural-BP: A specific GSE branded form validated for blood pressure reduction in multiple RCTs.
  • Bioavailability of OPCs is low (~15–20%) but complex monomers (catechins) are better absorbed than large oligomers; colonic microbiome metabolism generates additional bioactive metabolites.

Safety & Side Effects

  • Excellent safety profile; no serious adverse events in RCTs up to 2,500 mg/day.
  • Mild GI effects (nausea, diarrhea) at very high doses.
  • Anticoagulant effects: Antiplatelet activity; monitor with warfarin or other anticoagulants.
  • Drug interactions (see below): Most important are anticoagulant and chemotherapy interactions.
  • Tannins may reduce iron absorption (take away from iron supplements).

Drug & Supplement Interactions

Agent Interaction Management
Warfarin / anticoagulants Antiplatelet + possible warfarin potentiation Monitor INR; inform prescriber
Iron supplements OPCs chelate iron → reduced absorption Separate by 2+ hours
CYP3A4 substrates OPCs may inhibit CYP3A4 (moderate inhibitor) Caution with narrow-therapeutic-index CYP3A4 drugs
Rosuvastatin Pycnogenol may increase rosuvastatin plasma levels Monitor

Who Should Consider It

  • Adults with chronic venous insufficiency, leg edema, or varicose vein symptoms
  • Hypertensive individuals seeking adjunct antioxidant-driven BP support
  • Metabolic syndrome patients looking to reduce oxidized LDL and CRP
  • Those concerned about cognitive aging or managing ADHD symptoms adjunctively
  • Skin health–focused individuals (collagen protection, UV resilience)

Bottom Line

GSE and Pycnogenol are high-utility OPC supplements with real vascular and venous benefits at 150–300 mg/day and a very good safety profile—excellent "workhorse" vascular botanicals for CVI, blood pressure, and oxidative LDL support. The main cautions are antiplatelet effects in anticoagulant users and CYP3A4-mediated drug interactions. MegaNatural-BP is the GSE form specifically validated for blood pressure; Pycnogenol is the reference extract for CVI and ADHD applications.

Last reviewed: 2026.